Phase Ib study of HSP90 inhibitor, onalespib (AT13387), in combination with paclitaxel in patients with advanced triple-negative breast cancer.
Nicole O WilliamsDionisia QuirogaCourtney JohnsonAdam BrufskyMara ChambersSaveri BhattacharyaMaria PattersonSagar D SardesaiDaniel StoverMaryam LustbergAnne M NoonanMathew CherianDarlene M BystryKasey L HillMin ChenMitch A PhelpsMichael GreverJulie A StephensBhuvaneswari RamaswamyWilliam E CarsonRobert WesolowskiPublished in: Therapeutic advances in medical oncology (2023)
Onalespib and paclitaxel in treating patients with advanced TNBC https://clinicaltrials.gov/ct2/show/NCT02474173.